Target intelligence / Profile preview

MicroRNA recognition element (MRE)

Target
MRE
Molecular classification
RNA regulatory element, Non-coding RNA binding site
01

Overview

MicroRNA recognition elements (MREs) are specific nucleotide sequences, primarily located within the 3' untranslated regions (3'-UTRs) of messenger RNAs (mRNAs), that serve as the binding sites for microRNAs (miRNAs) (Bartel, 2009). These elements are central to post-transcriptional gene regulation, where the binding of a miRNA-loaded RNA-induced silencing complex (miRISC) typically results in translational repression or mRNA degradation (Jonas & Izaurralde, 2015). A single mRNA transcript often contains multiple MREs, allowing for complex, combinatorial regulation by multiple miRNAs, a phenomenon often exploited by competing endogenous RNAs (ceRNAs) that act as 'sponges' to sequester miRNAs (Helwak et al., 2013). In various diseases, such as cancer and viral infections, the interaction between miRNAs and MREs is frequently dysregulated, leading to the aberrant expression of oncogenes or the stabilization of viral genomes (Gebert & MacRae, 2019). Therapeutic intervention targeting these elements involves the use of antisense oligonucleotides known as 'target site blockers' (TSBs), which physically occupy the MRE to prevent miRNA binding and restore target gene expression (Stenvang et al., 2012). This approach provides a high level of specificity, enabling the modulation of a single miRNA-mRNA interaction without affecting the broader regulatory network of the miRNA.

Other names
miRNA binding sitemiRNA response element3'-UTR seed match sitemiRNA target siteMicroRNA response element
02

Mechanism of action

Steric inhibition of microRNA binding to the 3'-UTR of target mRNA transcripts, preventing the microRNA-induced silencing complex (miRISC) from initiating mRNA degradation or translational repression.

03

Biological functions

Post-transcriptional gene regulationmRNA degradationTranslational inhibitionGene silencing
04

Disease associations

CancerInfectionCardiovascular diseaseNeurodegenerative diseaseGenetic disorder
05

Safety considerations

Off-target hybridization to unintended mRNA sequencesSaturation of cellular RNA-binding proteinsUnintended upregulation of oncogenesDisruption of endogenous RNA processing pathways
06

Interacting drugs

Miravirsen

4 more in the full profile.

07

Biomarkers

miRNA expression levelsTarget mRNA stabilityProtein expression levelsmiRNA-mRNA interaction profiles

Beyond the preview

Go deeper on MicroRNA recognition element (MRE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA recognition element (MRE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call